NCT00620256View on ClinicalTrials.gov

Adjunctive Study of AL-37807 Ophthalmic Suspension

PHASE2CompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Open-Angle GlaucomaOcular Hypertension
Interventions
DRUG

AL-37807 ophthalmic suspension, 0.1%

DRUG

Timolol gel forming solution, 0.5%

OTHER

AL-37807 ophthalmic solution vehicle

DRUG

Latanoprost ophthalmic solution

Trial Locations (1)

76134

Contact Alcon Call Center at 1-888-451-3937, Fort Worth

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT00620256 - Adjunctive Study of AL-37807 Ophthalmic Suspension | Biotech Hunter | Biotech Hunter